人结直肠癌细胞LoVo构建于1971年,来源于一名56岁的白人男性结直肠癌患者转移到左锁骨位置的一个肿瘤结节。CSAp和结肠抗原3(colon antigen 3)表达阴性。肿瘤基因c-myc、K-ras、H-ras、 N-ras、Myb, sis和fos表达阳性,但未检测到 N-myc表达。该细胞表达肿瘤特定的核基质蛋白CC-3和CC-4。
组织来源/Tissue and Cell Type :结肠;分离自转移灶:左锁骨上区域
形态/Morphology: 上皮细胞样,贴壁生长
STR位点/STR profile:
Source(s): AddexBio; ATCC; CCRID; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=15771911; PubMed=25877200; PubMed=25926053; RCB
Markers:
Amelogenin X,Y
CSF1PO 11,13,14 (ATCC; ECACC; JCRB; PubMed=25926053)
11,14 (Cosmic-CLP)
11,12,14 (DSMZ)
10,11,13,14 (AddexBio; CCRID; CLS; PubMed=25877200)
10,14 (KCLB)
11,12,13 (RCB)
D2S1338 17,18 (CCRID; PubMed=25877200)
16,17,18 (PubMed=15771911)
D3S1358 14,16,17,18 (CCRID)
14,18 (KCLB; PubMed=25877200_584429)
14,16 (PubMed=15771911)
14,17 (PubMed=25877200_130903)
D5S818 11,12,13 (AddexBio; ATCC; DSMZ; JCRB; PubMed=25926053; RCB)
11,13 (CCRID; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)
D7S820 9.3,10,11 (AddexBio; ATCC; CCRID; DSMZ; PubMed=25877200; PubMed=25926053)
10,11 (CLS; Cosmic-CLP; ECACC; JCRB; KCLB; RCB)
D8S1179 10 (CCRID; PubMed=25877200)
9,10 (PubMed=15771911)
D13S317 8,11
D16S539 9,12 (AddexBio; ATCC; CCRID; CLS; Cosmic-CLP; ECACC; JCRB; PubMed=15771911; PubMed=25877200; PubMed=25926053; RCB)
9,11,12 (DSMZ)
D18S51 13,18 (CCRID; CLS; PubMed=15771911; PubMed=25877200)
13,17,18 (PubMed=11416159)
D19S433 14,15 (CCRID; PubMed=25877200)
15 (PubMed=15771911)
D21S11 29,31.2 (CCRID; PubMed=15771911; PubMed=25877200; PubMed=25926053)
29,31.2,32.2 (CLS)
FGA 18,20
Penta D 9,10,14 (CLS)
10,14 (PubMed=25877200)
Penta E 10,16
SE33 19.2,20.2,25.2
TH01 9.3
TPOX 8,9
vWA 17,18 (AddexBio; ATCC; CCRID; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=25877200; PubMed=25926053; RCB)
16,17,19 (DSMZ)
17,19 (PubMed=15771911)
Run an STR similarity search on this cell line
培养基和添加剂/Complete Growth Medium and Culture Conditions:
90%F12K(MD0400)+10%胎牛血清(SD0200)+G/A (SD0038)
完全培养基:F12K完全培养基(货号:MD0401)
气相:空气,95%;二氧化碳,5%。 温度:37摄氏度。
完全冻存液:无血清细胞冻存液(SD0002)
注意事项:此产品仅供科研使用

